Skip to Content

SG 332 (Nevirapine Extended-Release 100 mg)

Pill with imprint SG 332 is Yellow, Round and has been identified as Nevirapine Extended-Release 100 mg. It is supplied by ScieGen Pharmaceuticals Inc..

Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SG 332

Nevirapine Extended-Release

Imprint:
SG 332
Strength:
100 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
ScieGen Pharmaceuticals Inc.
National Drug Code (NDC):
50228-0332

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide